outdoor air and 0.07-11.5 ppb in indoor air for the general population. 1, 4 Other potential routes include ingestion and dermal contact, although the latter usually occurs occupationally in certain jobs that involve direct exposure to styrene. 7 Dermal absorption of styrene can contribute a significant amount to total exposure 8 and occurs even among styrene workers using respirators as personal protective equipment (PPE). 7 While the carcinogenic potential of styrene remains heavily disputed based on a lack of human evidence, there is a sizeable body of evidence surrounding its neurotoxicity in humans, with observed impairments in indices like reaction time, vibration perception, hearing, and nerve conduction velocity.
3,4
Industrial workers-particularly those in fiberglass-reinforced plastics (FRP) production for items like car parts, boats, and bathtubs-are most likely to be exposed to potentially neurotoxic concentrations of styrene (>1000 times higher than those encountered in the environment). Table SI provides an overview of airborne styrene exposure limits prescribed by various national and international agencies and organizations.
As neurotoxicant-induced impairment of color vision (dyschromatopsia) is an early marker of neurotoxicity, 9 previous research efforts have aimed to elucidate the relationship between styrene exposure and dyschromatopsia. In these studies, dyschromatopsia is most commonly measured using the Lanthony D-15 hue desaturated panel (D-15d) . This test evaluates a subject's ability to arrange 15 lowsaturation, colored caps in a defined chromatic sequence. 10 The D-15d was designed to detect mild dyschromatopsia in individuals who successfully complete the standard Farnsworth D-15 test, 11 which assesses more severe deficits in chromatic discrimination. [12] [13] [14] The D15d is also useful for classifying color vision defects, based on the confusion axis on which the predominance of errors occur (blueyellow, red-green, or both). According to Köllner's rule on acquired dyschromatopsia, blue-yellow defects suggest retinal dysfunction, while impairment of red-green discrimination (generally a more advanced development) indicates optic nerve disease. 15, 16 Acquired deficiencies in color vision are generally subtle and subclinical in nature. 14 Moreover, they are potential manifestations of various pathological conditions, including diabetes mellitus, 17, 18 Parkinson's disease, 19 and chronic alcoholism. 20 By providing sensitive early markers, dyschromatopsia-related findings may be useful for initiating treatment, as well as monitoring the progression of disease and injury. 18, 21 While there are two previous meta-analyses of styrene-induced dyschromatopsia, they are over a decade old and produced conflicting results. 13, 22 In addition, the potential implications of styrene-induced color vision loss with respect to instrumental activities of daily living (IADLs) are not well described. Herein, we conducted a joint systematic review and meta-analysis to elucidate the impact of occupational styrene exposure on color discrimination. Furthermore, we investigated the characteristics and potential implications underlying acquired dyschromatopsia in styrene workers.
| MATERIALS AND METHODS

| Search strategy
We queried the PubMed (https://www.ncbi.nlm.nih.gov/pubmed), EMBASE (https://www.embase.com), and Web of Science (https:// www.webofknowledge.com) electronic literature databases using the following search command: Styrene AND (Dyschromatopsia OR "color vision" OR "Retinal Cone Photoreceptor Cells" OR "Color Vision Defects"). No restrictions related to the date of publication or study design were implemented for this initial literature search, which was conducted on October 1, 2016. As part of a preliminary screen, we reviewed publication titles and abstracts of identified records. Studies were excluded if they were determined to be (a) review articles; (b) animal or laboratory studies;
| Study selection strategy
and/or (c) unavailable in the English language. Additionally, records that clearly lacked relevance to the subject of this review were removed from further consideration. Next, in an assessment of study eligibility for systematic review, we read the full-text articles for the remaining records. We deemed studies ineligible if they (a) did not include a direct measurement of styrene exposure (either biological or airborne); (b) indicated significant co-exposure of subjects to chemicals other than styrene, without identifying styrene exposure as the primary exposure of interest; or (c) reported findings contained within another eligible study (in which case we included the more recent study with the longer follow-up). To ensure full coverage of pertinent literature, we also examined reference lists of eligible studies. For meta-analysis, we synthesized only those studies that compared color discrimination indices between styrene-exposed and non-exposed participants using the D-15d test.
| Data extraction
We extracted the following descriptive information, as applicable: 
| Meta-analysis
In preparation for meta-analysis, we transformed mean CCIs and associated standard deviations into their natural logarithmic equivalents. 23 The decision to conduct a meta-analysis in the logarithmic scale was prompted by two observations. First, one of the eligible studies 24 reported dyschromatopsia using geometric means and standard deviations, rather than arithmetic values. As the standardized mean difference (the effect size variable of interest) assumes normality in a given outcome, and normality is more likely to hold for the logarithm of CCI than the CCI itself, we determined that data analysis in the logarithmic scale was warranted for all studies. A preliminary calculation of effect sizes in the original non-logarithmic scale had indicated considerable variability among estimates. Thus, we reasoned that calculation of log-transformed effect sizes would also help weaken the mean-variance relationship, which none of the previous meta-analyses had done. 13, 22 Assuming heterogeneity across studies, we employed a random effects model to investigate the effect of styrene exposure on CCI. As we had fewer than ten studies, we quantified exposure effects using estimates of Hedges' g, which offer bias-corrected standardized mean differences. 25 We were unable to recover Hedges' g from one study description 24 ; however, we were able to obtain Cohen's d. 26 Specifically, we used the reported two-sided P-value (derived from a log-scale comparison by the authors) to determine a t-test statistic FIGURE 1 Flow diagram illustrating the study selection process. Exclusions from qualitative synthesis were conducted in two consecutive steps, screening and eligibility assessment (involving title/abstract review and full-text review, respectively). Separate exclusion criteria were applied to select studies for meta-analysis from which we could directly calculate the effect size. 27 Calculations of Hedges' g were performed using exact formulae, rather than small sample approximations, which have been shown to be unreliable and impractical with modern software. 28 Outcomes were pooled using the inverse variance method. We depicted effect estimates and confidence intervals for all analyzed studies on a forest plot. In addition, a funnel plot was created for assessment of publication bias. To supplement visual inspection of the funnel plot, we conducted Egger's linear regression test of funnel plot asymmetry, 33 modified to accommodate between-study heterogeneity. 34 Moreover, we employed the nonparametric trim-and-fill method. This analysis involves estimating the number of missing studies in a meta-analysis and hypothetically correcting funnel plot asymmetry, to gauge the effect that these missing studies would demonstrate upon inclusion. 35 Although the method assumes a fixed effects model, it should perform adequately under random effects models with low-to-moderate levels of between-study heterogeneity. 36 We conducted the analyses using the "metacont" function in the R software (4.7.0) "meta" package. 37, 38 studies were excluded due to significant evidence of co-exposure to numerous solvents. Moreover, one study 40 was excluded because its primary findings were incorporated into a larger, cohort study by the same research group. 41 In aggregate, 15 studies 24,41-54 were selected for qualitative synthesis (Table 1 ). Among the 15 included studies, eight 24, 43, [45] [46] [47] 49, 51, 54 were eligible for meta-analysis based on the criteria described above in the Methods section (Figure 2 ).
3.2 | Characteristics of included studies and subjects States. 52 We noted considerable overlap among the investigators overseeing the selected studies; eight independent research groups could be discerned from the author lists.
All studies characterized subjects as "exposed" strictly according to the nature of their occupation (ie, involving direct exposure to styrene). In all but two studies, 53,54 exposed subjects were explicitly linked to reinforced plastics manufacture, most commonly as painters and laminators. Exclusion criteria varied across studies but typically entailed excess alcohol consumption, tobacco smoking, and congenital dyschromatopsia, as defined by the authors. Diabetes, hypertension, cerebrovascular disease, and poor (corrected) visual acuity were also commonly cited as exclusion criteria. Although three studies acknowledged past or present co-exposure to other substances (most studies did not address this consideration), the authors suggested that the levels of exposure were sufficiently low to be considered negligible (Table 2 ). In the nine studies that reported statistically significant confounding variables, age was always among the reported covariates. Other covariates (such as alcohol consumption and tobacco smoking) were less commonly reported.
Four studies specified a minimum duration of employment (ranging from 6 months to 5 years) in their inclusion criteria. Workers tended to exhibit long tenures of employment, and the lowest mean or median duration of exposure in any study was 4.5 years. Among the eight studies that divulged details about the workers' use of personal protective equipment (PPE), four reported little to no use of cartridge masks ( Table 2 ). Authors of more recent studies tended to report increased PPE use and/or recent systemic improvements in training and ventilation; these were general reflections of temporal changes in worker safety, seldom supported by longitudinal analysis.
Nine studies recruited referent subjects without occupational exposure to styrene or other industrial solvents. Lack of occupational styrene exposure was assumed on the basis of one's job title. Nonexposed subjects were often matched to their exposed counterparts for sex and age, and less frequently for alcohol consumption, tobacco smoking, socioeconomic status, and ethnicity. Only two studies reported that all non-exposed subjects worked at the same plant(s) that employed the styrene workers. 24, 54 These two studies were also the only studies that described a quantitative assessment of styrene examining urinary biomarkers of styrene exposure that also accounted for urine dilution with urinary creatinine concentrations, whole-study mean concentrations for urinary MA varied between 84.0 and 360 mg/g creatinine, and average urinary PGA varied between 57.4 and 110 mg/g creatinine. As is evident from the case report by Gobba et al 48 individual concentrations could fall significantly outside of these ranges, however. In both studies that measured biological styrene exposure in non-exposed participants, 24 ,54 styrene metabolite levels were confirmed to be significantly lower than those of exposed subjects, displayed in Table 2 .
For the control group, Chia et al 24 reported a mean MA value of 3.3 mg/g creatinine (range: 1.6-9.6 mg/g creatinine) and a mean PGA value of 0.7 mg/g creatinine (range: 0.3-1.9 mg/g creatinine).
Meanwhile, Triebig et al 54 Eleven studies elaborated on the characteristics of the observed color vision deficits; impairment in chromatic discrimination manifested mostly by blue-yellow deficiency (Table 3) . Five studies described the deficits as subclinical (the rest of the studies did not address their clinical significance). One study made exclusions based on red-green deficiency, 53 under the premise that the majority of deficits observed along this axis are congenital, and therefore, obfuscate the detection of acquired dyschromatopsia.
We observed mixed findings with respect to the reversibility of styrene-induced dyschromatopsia. The majority of studies with a 1-month follow-up after an exposure-free month did not show significant recovery of color vision. [45] [46] [47] Similarly, Seeber et al 53 did not find any evidence of reversibility following a 6-to 8-week vacation.
In contrast, Triebig et al 54 suggested that both 1-month and 10-month reductions in exposure significantly diminished the difference in CCI between non-exposed subjects and exposed subjects. Castillo et al 
| Synthesis of results
In total, we analyzed data from 352 styrene workers and 355 subjects without occupational styrene exposure (Figure 2 ). Pooled analysis using a random effects model led to an overall standardized mean difference (SMD) of 0.56 (95% confidence interval [CI]: 0.37, 0.76; P < 0.0001), which is interpreted as a medium-size effect. 26 A fixed effects model yielded a SMD of 0.53 (95%CI: 0.37, 0.68; P < 0.0001).
The 95%CIs of the mean differences from individual studies overlapped, suggesting between-study consistency. This was supported by formal examination of between-and within-study variation. The between-study variance component, τ
2
, was estimated at 0.0242. A test of between-study heterogeneity using Cochran's Q (Q = 23.2; df = 10; P = 0.171) was not significant, even at a less stringent significance cut-off of 0.10, as described by Dickersin and Berlin. 59 Consistent with this, the observed magnitude of I 2 (32.2%) denoted low-to-moderate heterogeneity. 31 Similarly, we observed that the corresponding 95%CI [0.0%, 69.9%]
FIGURE 3 Funnel plot of study-specific estimates of the standardized mean difference. The vertical dashed line passing through the apex of the funnel represents the effect size estimate derived from fixed effects analysis. The estimated effect size from random effects analysis is also herein depicted as a vertical dotted line CHOI ET AL.
| 939 included both the low-level (25%) and moderate-level (50%) cut points described by Higgins et al; it did not contain the high-level (75%) cut point.
| Risk of publication bias
Upon initial visual inspection of the funnel plot, we did not observe any Notably, our meta-analysis contained fewer than the minimum number of studies (10) The evidence to date supports the hypothesis that chronic, occupational exposure to styrene at levels well below 100 ppm-the 8 h TWA permissible exposure limit defined by OSHA (Table SI) There was some evidence to suggest a dose-response relationship, which the earlier meta-analysis by Benignus et al 22 illustrated using individual-subject data. However, there was no clear consensus regarding the threshold exposure concentration that causes acquired dyschromatopsia. Deficits in color discrimination predominantly occurred along the blue-yellow axis, an observation that has been connected to early manifestation of dyschromatopsia. 47, 48, 52 Findings regarding the reversibility of this exposure effect were mixed (discrepancies were attributed to differences in exclusion criteria and exposure levels between studies) and in low abundance (coming from only five studies). Similar conclusions could be made with regard to studies of past peak exposure and its impact on color discrimination.
The evolution of styrene-induced dyschromatopsia remains unclear, and the pathogenic mechanism(s) that underlie this evolution similarly require(s) further investigation. Future studies could also investigate potential associations between acquired dyschromatopsia and other subtle manifestations of neurotoxicity.
Overall, we observed significant variation in study location, study design, and methods of exposure assessment between studies. We also found an overall inconsistency in work conditions and practices, which represents an important consideration for interpretation of styrene-induced dyschromatopsia. For instance, proper PPE use 60, 61 and improvements in ventilation systems and other work practices 62, 63 have been linked to reduced styrene body burden. Divergence in these study characteristics may explain, to some degree, the reports of pronounced between-study heterogeneity from earlier meta-analyses. 13, 22 While heterogeneity can complicate effect size calculation, the consistent finding of styrene-induced dyschromatopsia despite study-level variation supports the validity of this effect. Hence, the observed between-study heterogeneity represents both a strength and a limitation in this review. In contrast, we found significant homogeneity in both the methods of outcome assessment (14 of the 15 studies herein reviewed used the D-15d to assess dyschromatopsia) and the type of work site(s) from which exposed subjects were recruited (13 studies mentioned involvement in fiberglass-reinforced plastics manufacture).
Under the random effects assumption, meta-analysis yielded an 
| Limitations
With regard to limitations of the review process, our decision to restrict eligible studies to peer-reviewed papers available in the English language may have resulted in some bias and inaccuracy in our effect size estimate.
Other challenges to interpretation included small sample sizes and a paucity of relevant studies, which further hampered our assessment of heterogeneity and publication bias. It is also worth noting that this review lacked a comprehensive risk of bias analysis. Thus, the extent to which potential factors other than publication bias (eg, selection bias, confounding, and exposure misclassification) affected our determination of the exposure effect remains unclear. Future work incorporating systematic evaluation of these sources of bias would enhance causal interpretations of this literature.
We also identified other potential methodological limitations within studies. In the absence of a formal appraisal, we consider that the lack of blinding in 10/15 studies may have contributed to overestimation of the exposure effect due to observer bias. We also noted that some studies derived cumulative exposure from a simple multiplication of exposure duration with current exposure level. These estimations rely on the assumption of constant exposure levels, which is unlikely and difficult to prove without formal assessments (either biological or environmental). In addition, several studies used mean biological measurements to estimate airborne styrene levels through a linear relationship model; however, this model may not be accurate at high levels of exposure (>150 ppm) to which a contingent of workers were likely subjected. 64 Lastly, the D-15d panelwhile highly efficient and uniquely designed to identify acquired dyschromatopsia-can be accompanied by concerns of high false positive rates. 65, 66 Related to this, over-detection due to certain conditions of D-15d test administration (eg, low level of illumination during testing) may have contributed to effect size miscalculation.
| Implications for instrumental activities of daily living
No study has investigated the impact of styrene-induced dyschromatopsia on a person's ability to perform IADLs. Although the reviewed studies reported certain characteristics of the workers' dyschromatopsia, the aggregate pool of information was limited and incomplete. The two principal observations regarding the color vision deficits were their subclinical nature and predominance along the blue-yellow chromatic axis. Based on this information alone, the significance of the workers' dyschromatopsia with respect to their IADLs remains uncertain.
Studies of individuals with congenital dyschromatopsia (which presents most frequently as a red-green deficit) suggest that dyschromatopsia can lead to significant impairments in one's ability to perform IADLs. 67, 68 The clinical impact of acquired dyschromatopsia, in comparison, is not well studied. Consistent with this research gap, the confusion patterns of acquired dyschromatopsia tend to be more poorly defined than those that arise from congenital color blindness (commonly assessed using the Ishihara pseudoisochromatic plate test). 65, 66 The clinical implications surrounding acquired color vision deficiency warrant further investigation-especially in light of previous suggestions that acquired dyschromatopsia may actually be more prevalent (5-15%) than the congenital subtype (2-8%) in certain populations. 69 It is questionable whether the styrene-induced color vision defects herein discussed could interfere with IADLs. However, acquired dyschromatopsia is unique in its mutability (from blue-yellow to redgreen or a combination of both), and its level of severity has the potential to change according to the presence and intensity of the underlying exposure. 13, 15, 16, 53, 70 In addition to potential shifts in severity, the very nature of the deficits may change. Some have suggested a model of occupational exposure wherein early manifestations of dyschromatopsia occur along the blue-yellow axis, but, upon continued exposure, evolve to include more clinically significant defects in red-green discrimination. 14, 47, 48, 52, 65, 71 A similar model has been described for acquired dyschromatopsias associated with ocular disease. 15, 65 In sum, these models are not well characterized and require further examination. Nonetheless, they bring forth an intriguing possibility with regard to styrene-induced dyschromatopsiaespecially given that most studies in our review identified redgreen defects in a small contingent of subjects. The only crosssectional or cohort study that did not report any cases of red-green dyschromatopsia was that conducted by Seeber et al 53 to-severe deficits in visual acuity. 15, 72 There is evidence to suggest that among all visual measures, visual acuity is most strongly correlated with observed performance of IADLs. 73 The likelihood of this particular outcome in the styrene workers is unclear, however, given that visual acuity was examined only for screening purposes. In addition, as investigators typically excluded subjects with poor (corrected) visual acuity, the association between visual acuity loss and styrene-induced dyschromatopsia remains unclear. Ultimately, acquired dyschromatopsias are fundamentally complex and unpredictable in their prognosis. 15 Thus, until the emergence of carefully planned studies built around this research question, one can only speculate about the "realworld" implications of styrene-induced dyschromatopsia.
| Future directions
Our review highlights the need for more focused research efforts in several areas, including:
1. The dose dependence of the exposure-outcome relationship and its associated threshold level of exposure.
2. The evolution of color vision loss upon increased or prolonged exposure, including associated pathogenic mechanism(s).
3. The potential reversibility of styrene-induced dyschromatopsia upon reduced exposure.
4.
Effects of short-term styrene exposure on color discrimination in humans. Only one study to date has examined this effect 74 ; in this experimental study, subjects without prior occupational styrene exposure did not exhibit significant dyschromatopsia after exposure to five 6 h-long sessions (peak 50 ppm) inside an exposure chamber.
5.
The impact of styrene exposure with respect to other neurological endpoints (such as delayed reaction, hearing loss, and impaired vibration perception), which have individually received less attention in human studies than has acquired dyschromatopsia.
6. Effects of dyschromatopsia and styrene-induced neurological effects more generally on IADLs.
7.
Potential methodological improvements for the study of D-15d results from styrene-exposed workers. These include increased use of the Vingrys and King-Smith Confusion index, 75 which provides a detailed evaluation of early color vision loss that may be more suitable and useful (relative to the CCI index) for this occupational setting. 13, 46 8. The practical application of biological monitoring (using sensitive blood and urinary indices) in exposure evaluation of styrene workers, so as to address salient issues such as workload differences.
9. Current work conditions and practices at high-exposure sites (eg, fiberglass-reinforced plastics plants). Future studies should prioritize accurate and thorough assessments of exposure that rely on the usual biological and environmental measures, but could also consider assays of dermal exposure to avoid underestimation of occupational exposure.
| CONCLUSIONS
Our review indicates that prolonged occupational exposure to styrene, at levels below most regulatory agency-prescribed exposure limits, can impair color discrimination. Acknowledging the small number of studies in our review, our quantitative analyses suggested a medium-size effect size with low-to-moderate heterogeneity between studies. The consistency of results across studies despite use of divergent methods and work practices further substantiates the styrene exposure effect.
Several questions remain regarding dyschromatopsia due to occupational styrene exposure; these include questions about the seemingly low dose-response threshold, the evolution of color vision loss over time, associated pathogenic mechanism(s), and the effects of acute versus chronic exposure. In addition, the significance of styreneinduced dyschromatopsia (and other neurological impairments) as it pertains to IADLs is unclear. Future studies should place an emphasis on extensive and accurate measurement of styrene exposure, to clarify the exposure-outcome relationship and evaluate the usefulness of currently prescribed exposure limits.
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